SLRC Stock News 21.36 05/13/2014 05:56:18 Solar Capital Ltd

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Solar Capital Ltd (SLRC) 21.36 $SLRC

3 Buy-Rated Dividend Stocks To Check Out: SLRC, PAC, CRT
at The Street - Mon May 12, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

American Capital (ACAS) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 08, 8:18AM CDT
American Capital, Ltd. (ACAS) was a big mover last session, as the company saw its shares rise by over 6% on the day.

Ares Capital Reports in Line Earnings, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 11:00AM CDT
Share price of Ares Capital Corporation (ARCC) slumped by 2.8% following its first quarter 2014 earnings release on Tuesday before the opening bell as well as negative broader market sentiments.

Solar Capital Ltd. Announces Quarter Ended March 31, 2014 Financial Results; Declares Quarterly Distribution of $0.40 per share for Q2, 2014
Business Wire - Mon May 05, 4:00PM CDT
Solar Capital Ltd. (the "Company" (NASDAQ:SLRC), today reported earnings of $13.8 million, or $0.31 per share for the quarter ended March 31, 2014. Net investment income was $17.4 million, or $0.40 per average share, for the first quarter. At March 31, 2014, net asset value (NAV) per share was $22.43.

Is a Surprise Coming for Solar Capital (SLRC) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 05, 7:45AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Solar Capital may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

Don't Miss Out: Top 3 Yielding Buy-Rated Stocks: SLRC, FDUS, BKCC
at The Street - Thu May 01, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

Fitch Affirms Solar Capital at 'BBB-'; Outlook Stable
Business Wire - Mon Apr 28, 3:43PM CDT
Fitch Ratings has affirmed Solar Capital, Ltd.'s (Solar) long-term Issuer Default Rating (IDR), secured debt rating, and unsecured debt rating at 'BBB-'. The Rating Outlook is Stable. These actions are being taken in conjunction with a broader industry review, which includes seven business development companies (BDCs), and coincides with the publication of an industry report, titled 'Business Development Companies - A Comparative Analysis: 2013', which is available on Fitch's website.

3 Buy-Rated Dividend Stocks: SLRC, PFLT, MCC
at The Street - Tue Apr 22, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

Solar Capital Ltd. Schedules Earnings Release for the Quarter Ended March 31, 2014
Business Wire - Wed Apr 16, 3:00PM CDT
Solar Capital Ltd. (NASDAQ:SLRC), today announced that it will release its financial results for the quarter ended March 31, 2014 on Monday, May 5, 2014, after the close of the financial markets.

Buy-Rated Dividend Stocks: Top 3 Companies: TCAP, SLRC, FULL
at The Street - Fri Apr 11, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

3 Buy-Rated Dividend Stocks Taking The Lead: SLRC, FDUS, FULL
at The Street - Tue Apr 01, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

3 Buy-Rated Dividend Stocks Taking The Lead: SLRC, PZN, MNDO
at The Street - Thu Mar 20, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

3 Stocks Going Ex-Dividend Tuesday: ARMF, MIN, SLRC
at The Street - Mon Mar 17, 9:02AM CDT
ARMF MIN SLRC are going ex-dividend Tuesday, Tuesday, March 18, 2014, 4:00 AM ET

Best 3 Yielding Buy-Rated Stocks: SLRC, DOM, MCEP
at The Street - Fri Mar 07, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

VDA Productions Celebrates Award-Winning Designs and Award-Winning Team
PR Newswire - Wed Feb 26, 8:00AM CST
VDA Productions, the premier provider of 3D marketing experiences and design solutions that bring brands to life for Corporate Meetings, Tradeshows, Themed Events, Exhibits, Themed Retail Environments and Corporate Facilities, today announces that Susan Prue Senior Sales Account Executive, was recognized as an industry leader in Collaborate magazineʼs "40 Under 40" feature in the February/March 2014 issue. Collaborate magazine is a national, B2B magazine that provides resources and ideas to planners in the corporate meetings industry.

Solar Capital Ltd. Announces Quarter and Fiscal Year Ended December 31, 2013 Financial Results; Declares Quarterly Dividend of $0.40 per share for First Fiscal Quarter 2014
Business Wire - Tue Feb 25, 3:31PM CST
Solar Capital Ltd. (NASDAQ:SLRC), today reported earnings of $28.9 million, or $0.65 per share for the quarter ended December 31, 2013 and $75.3 million, or $1.69 per share, for the fiscal year ended December 31, 2013. Net investment income was $18.5 million, or $0.42 per share, for the fourth quarter and $84.9 million, or $1.91 per share, for the fiscal year. Net asset value (NAV) per share was $22.50 at December 31, 2013, up from $22.25 at September 30, 2013.

What To Buy: Top 3 Buy-Rated Dividend Stocks: SLRC, PVR, MCC
at The Street - Mon Feb 24, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

Buy-Rated Dividend Stocks In The Top 3: SLRC, NMM, CLMT
at The Street - Mon Feb 10, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

Buy-Rated Dividend Stocks: Top 4 Companies: SLRC, AI, QRE, ARI
at The Street - Thu Jan 30, 9:30AM CST
These 4 dividend stocks are rated a Buy by TheStreet

Solar Capital Ltd. Schedules Earnings Release for the Fiscal Year Ended December 31, 2013
Business Wire - Mon Jan 27, 3:01PM CST
Solar Capital Ltd. (NASDAQ:SLRC), today announced that it will release its financial results for the year ended December 31, 2013 on Tuesday, February 25, 2014, after the close of the financial markets.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading